Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.36ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-15795Japan
CR.1.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-15795Japan
B.1.112SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-15806Singapore
FL.15.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-15821.4South Korea
AY.110 (Delta)ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-15821.4South Korea
JD.1.1.1ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-15822.5Japan
JN.1.39.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
JN.1.43.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
GJ.1.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
B.1.1.404NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
AY.51 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
P.3 (Theta)SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-15856Japan
B.19ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-15870.7China
BA.2.67ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15887.1Japan
AY.50 (Delta)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-15894.3China
XBB.1.6SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-15898.9Japan
JG.4SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-15898.9Japan
AY.3.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-15913.9Singapore
HK.27.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-15915.9Singapore
XBB.1.5.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-15931.5Singapore
XBUORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-15947.1China
B.1.625ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-15969.5China
AY.78 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
A.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
BQ.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
HC.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
GW.5.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
B.1.36.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
XAY.3ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15983.8France
B.55SWon-SCTACATGCACCAGCAACTGT20502311423133F-15985.6South Korea
BQ.1.1.47SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-15991.3Japan
JW.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-15991.3Japan
D.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-15991.3Japan
AY.120.1 (Delta)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-15991.3Japan
BE.10ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-15991.3Japan
C.38SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-16029Japan
B.1.602SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-16029Japan
XBSNCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-16039.2China
B.1.1.360SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16052.8Japan
B.1.501ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
B.1.252ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
XBB.6.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
JD.2.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
JN.1.59ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
XBB.1.5.28ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
BA.5.2.44ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
BE.8ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
XBB.6ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
B.1.1.47ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-16083.7Singapore
GA.3ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-16105.1France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used